+

WO2003003984A8 - Novel proteins and nucleic acids encoding same - Google Patents

Novel proteins and nucleic acids encoding same Download PDF

Info

Publication number
WO2003003984A8
WO2003003984A8 PCT/US2002/021268 US0221268W WO03003984A8 WO 2003003984 A8 WO2003003984 A8 WO 2003003984A8 US 0221268 W US0221268 W US 0221268W WO 03003984 A8 WO03003984 A8 WO 03003984A8
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
acids encoding
encoding same
novel proteins
proteins
Prior art date
Application number
PCT/US2002/021268
Other languages
French (fr)
Other versions
WO2003003984A9 (en
WO2003003984A2 (en
Inventor
Elma R Fernandes
Corine A M Vernet
Richard A Shimkets
David W Anderson
Muralidhara Padigaru
Ferenc L Boldog
Li Li
Suresh G Shenoy
Stacie J Casman
Luca Rastelli
John P Ii Alsobrook
Catherine E Burgess
William M Grosse
Vladimir Y Gusev
Weizhen Ji
Denise M Lepley
Xiaohong Liu
Amanda J Mezick
Meera Patturajan
Lei Shen
Steven K Spaderna
Kimberly A Spytek
Edward S Szekeres Jr
Raymond J Taupier Jr
Velizar T Tchernev
Bryan D Zerhusen
Edward Z Voss
Original Assignee
Curagen Corp
Elma R Fernandes
Corine A M Vernet
Richard A Shimkets
David W Anderson
Muralidhara Padigaru
Ferenc L Boldog
Li Li
Suresh G Shenoy
Stacie J Casman
Luca Rastelli
John P Ii Alsobrook
Catherine E Burgess
William M Grosse
Vladimir Y Gusev
Weizhen Ji
Denise M Lepley
Xiaohong Liu
Amanda J Mezick
Meera Patturajan
Lei Shen
Steven K Spaderna
Kimberly A Spytek
Edward S Szekeres Jr
Raymond J Taupier Jr
Velizar T Tchernev
Bryan D Zerhusen
Edward Z Voss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/966,545 external-priority patent/US20020172999A1/en
Application filed by Curagen Corp, Elma R Fernandes, Corine A M Vernet, Richard A Shimkets, David W Anderson, Muralidhara Padigaru, Ferenc L Boldog, Li Li, Suresh G Shenoy, Stacie J Casman, Luca Rastelli, John P Ii Alsobrook, Catherine E Burgess, William M Grosse, Vladimir Y Gusev, Weizhen Ji, Denise M Lepley, Xiaohong Liu, Amanda J Mezick, Meera Patturajan, Lei Shen, Steven K Spaderna, Kimberly A Spytek, Edward S Szekeres Jr, Raymond J Taupier Jr, Velizar T Tchernev, Bryan D Zerhusen, Edward Z Voss filed Critical Curagen Corp
Priority to AU2002327198A priority Critical patent/AU2002327198A1/en
Publication of WO2003003984A2 publication Critical patent/WO2003003984A2/en
Publication of WO2003003984A9 publication Critical patent/WO2003003984A9/en
Publication of WO2003003984A8 publication Critical patent/WO2003003984A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/US2002/021268 2001-07-05 2002-07-03 Novel proteins and nucleic acids encoding same WO2003003984A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002327198A AU2002327198A1 (en) 2001-07-05 2002-07-03 Novel proteins and nucleic acids encoding same

Applications Claiming Priority (22)

Application Number Priority Date Filing Date Title
US30316801P 2001-07-05 2001-07-05
US30324101P 2001-07-05 2001-07-05
US60/303,241 2001-07-05
US60/303,168 2001-07-05
US09/966,545 US20020172999A1 (en) 1999-04-09 2001-09-26 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
US09/965,212 US20030003462A1 (en) 1999-04-09 2001-09-26 Novel human interleukin-like proteins and polynucleotides encoding them
US09/966,545 2001-09-26
US09/966,546 US20020168716A1 (en) 1999-04-09 2001-09-26 Novel amino acid sequences for human microfibril glycoprotein 4-like polypeptides
US09/965,212 2001-09-26
US09/966,546 2001-09-26
US36899602P 2002-04-01 2002-04-01
US36906502P 2002-04-01 2002-04-01
US60/369,065 2002-04-01
US60/368,996 2002-04-01
US37873002P 2002-05-08 2002-05-08
US60/378,730 2002-05-08
US38432702P 2002-05-30 2002-05-30
US60/384,327 2002-05-30
US38681602P 2002-06-07 2002-06-07
US60/386,816 2002-06-07
US17437202A 2002-06-17 2002-06-17
US10/174,372 2002-06-17

Publications (3)

Publication Number Publication Date
WO2003003984A2 WO2003003984A2 (en) 2003-01-16
WO2003003984A9 WO2003003984A9 (en) 2009-05-22
WO2003003984A8 true WO2003003984A8 (en) 2009-08-13

Family

ID=27581222

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/021268 WO2003003984A2 (en) 2001-07-05 2002-07-03 Novel proteins and nucleic acids encoding same

Country Status (1)

Country Link
WO (1) WO2003003984A2 (en)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003230775A1 (en) * 2002-04-01 2003-10-20 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
ES2605443T3 (en) 2003-11-06 2017-03-14 Seattle Genetics, Inc. Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
AU2005249490B2 (en) 2004-06-01 2010-07-29 Genentech, Inc. Antibody drug conjugates and methods
ES2669510T3 (en) 2004-09-23 2018-05-28 Genentech, Inc. Antibodies and conjugates engineered with cysteine
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
EP2475391B1 (en) 2009-09-09 2018-09-12 Centrose, LLC Extracellular targeted drug conjugates
TWI540136B (en) 2010-04-15 2016-07-01 梅迪繆思有限公司 Pyrrolobenzodiazepines and conjugates thereof
AU2011265054B2 (en) 2010-06-08 2016-09-15 Genentech, Inc. Cysteine engineered antibodies and conjugates
WO2012074757A1 (en) 2010-11-17 2012-06-07 Genentech, Inc. Alaninyl maytansinol antibody conjugates
RU2638806C2 (en) 2011-05-12 2017-12-15 Дженентек, Инк. Lc-ms/ms method for multiple reactions monitoring to identify therapeutic antibodies in animal species using framework signature peptides
SG11201401406YA (en) 2011-10-14 2014-05-29 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
WO2013130093A1 (en) 2012-03-02 2013-09-06 Genentech, Inc. Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
PL2906253T3 (en) 2012-10-12 2019-02-28 Adc Therapeutics Sa Pyrrolobenzodiazepine - anti-psma antibody conjugates
WO2014057120A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-antibody conjugates
CA2941485C (en) 2012-10-12 2018-06-12 Philip Wilson Howard Pyrrolobenzodiazepines and conjugates thereof
PT2906296T (en) 2012-10-12 2018-06-01 Medimmune Ltd Pyrrolobenzodiazepine-antibody conjugates
HUE042731T2 (en) 2012-10-12 2019-07-29 Adc Therapeutics Sa Pyrrolobenzodiazepine antibody conjugates
HUE035694T2 (en) 2012-10-12 2018-05-28 Adc Therapeutics Sa Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
US10736903B2 (en) 2012-10-12 2020-08-11 Medimmune Limited Pyrrolobenzodiazepine-anti-PSMA antibody conjugates
EA031585B1 (en) 2012-12-21 2019-01-31 Медимьюн Лимитед Pyrrolobenzodiazepines and conjugates thereof
CN110627797A (en) 2012-12-21 2019-12-31 麦迪穆有限责任公司 Asymmetric pyrrolobenzodiazepine dimers for the treatment of proliferative and autoimmune diseases
EP2968585B1 (en) 2013-03-13 2018-07-18 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
KR102057755B1 (en) 2013-03-13 2019-12-19 메디뮨 리미티드 Pyrrolobenzodiazepines and conjugates thereof
EP2968594B1 (en) 2013-03-13 2019-04-24 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
JP6993084B2 (en) 2013-08-12 2022-02-03 ジェネンテック， インコーポレイテッド 1- (Chloromethyl) -2,3-dihydro-1H-benzo [E] indole dimer antibody-drug conjugate compound, and method of use and treatment
WO2015052534A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
EP3054983B1 (en) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
KR20170042495A (en) 2013-12-16 2017-04-19 제넨테크, 인크. Peptidomimetic compounds and antibody-drug conjugates thereof
CA2928952A1 (en) 2013-12-16 2015-06-25 Genentech, Inc. Peptidomimetic compounds and antibody-drug conjugates thereof
KR20160092024A (en) 2013-12-16 2016-08-03 제넨테크, 인크. 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
EP3193940A1 (en) 2014-09-10 2017-07-26 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
MX2017003123A (en) 2014-09-12 2017-05-12 Genentech Inc Cysteine engineered antibodies and conjugates.
CN106714844B (en) 2014-09-12 2022-08-05 基因泰克公司 Anthracycline disulfide intermediates, antibody-drug conjugates and methods
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
JP2017533887A (en) 2014-09-17 2017-11-16 ジェネンテック， インコーポレイテッド Pyrrolobenzodiazepines and their antibody disulfide conjugates
NZ731782A (en) 2014-11-25 2023-04-28 Medimmune Ltd Pyrrolobenzodiazepine-antibody conjugates
CN107206101B (en) 2014-12-03 2021-06-25 基因泰克公司 Quaternary ammonium compounds and antibody-drug conjugates thereof
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
MA43345A (en) 2015-10-02 2018-08-08 Hoffmann La Roche PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
MA43354A (en) 2015-10-16 2018-08-22 Genentech Inc CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE
MA45326A (en) 2015-10-20 2018-08-29 Genentech Inc CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
US20170315132A1 (en) 2016-03-25 2017-11-02 Genentech, Inc. Multiplexed total antibody and antibody-conjugated drug quantification assay
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
ES2858151T3 (en) 2016-05-20 2021-09-29 Hoffmann La Roche PROTAC-Antibody Conjugates and Procedures for Use
EP3465221B1 (en) 2016-05-27 2020-07-22 H. Hoffnabb-La Roche Ag Bioanalytical method for the characterization of site-specific antibody-drug conjugates
US10639378B2 (en) 2016-06-06 2020-05-05 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
CN109689111B (en) 2016-08-11 2024-04-05 基因泰克公司 Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
CN110139674B (en) 2016-10-05 2023-05-16 豪夫迈·罗氏有限公司 Method for preparing antibody drug conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
CN110267686B (en) 2017-02-08 2023-06-09 Adc治疗有限公司 Pyrrolobenzodiazepine-antibody conjugates
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
SI3612537T1 (en) 2017-04-18 2022-10-28 Medimmune Limited Pyrrolobenzodiazepine conjugates
ES2977788T3 (en) 2017-04-20 2024-08-30 Adc Therapeutics Sa Combination therapy with an anti-AXL antibody-drug conjugate
CA3064804A1 (en) 2017-06-14 2018-12-20 Adc Therapeutics Sa Dosage regimes for the administration of an anti-cd19 adc
JP7220203B2 (en) 2017-08-18 2023-02-09 メドイミューン・リミテッド pyrrolobenzodiazepine complex
AU2018337815A1 (en) 2017-09-20 2020-03-12 Ph Pharma Co., Ltd. Thailanstatin analogs
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
GB201814281D0 (en) 2018-09-03 2018-10-17 Femtogenix Ltd Cytotoxic agents
WO2020086858A1 (en) 2018-10-24 2020-04-30 Genentech, Inc. Conjugated chemical inducers of degradation and methods of use
JP2022513198A (en) 2018-12-10 2022-02-07 ジェネンテック， インコーポレイテッド Photocrosslinkable peptide for site-specific conjugation to Fc-containing proteins
GB201901197D0 (en) 2019-01-29 2019-03-20 Femtogenix Ltd G-A Crosslinking cytotoxic agents
CA3130174A1 (en) 2019-03-15 2020-09-24 Medimmune Limited Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
GB2597532A (en) 2020-07-28 2022-02-02 Femtogenix Ltd Cytotoxic compounds
WO2022078524A2 (en) 2021-11-03 2022-04-21 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody
TW202432187A (en) 2022-12-23 2024-08-16 美商建南德克公司 Cereblon degrader conjugates, and uses thereof
WO2024220546A2 (en) 2023-04-17 2024-10-24 Peak Bio, Inc. Antibodies and antibody-drug conjugates and methods of use and synthetic processes and intermediates

Also Published As

Publication number Publication date
WO2003003984A9 (en) 2009-05-22
WO2003003984A2 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
WO2003003984A9 (en) Novel proteins and nucleic acids encoding same
AU2002214531A1 (en) Proteins and nucleic acids encoding same
AU2002366951A1 (en) Novel nucleic acids and polypeptides
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2002314709A1 (en) Novel nucleic acids and polypeptides
AU2002343417A1 (en) Novel nucleic acids and polypeptides
AU2001288390A1 (en) Proteins and nucleic acids encoding same
AU2002220215A1 (en) Novel proteins and nucleic acids encoding same
WO2002094870A8 (en) Proteins and nucleic acids encoding same
EP1572995A3 (en) Novel proteins and nucleic acids encoding same
EP1383533A4 (en) Proteins and nucleic acids encoding same
AU2001239756A1 (en) Novel proteins and nucleic acids encoding same
AU2002211681A1 (en) Proteins and nucleic acids encoding same
AU2002250419A1 (en) Novel nucleic acids and polypeptides
AU2002249818A1 (en) Novel proteins and nucleic acids encoding same
AU2002330857A1 (en) Novel proteins and nucleic acids encoding same
AU2002322406A1 (en) Novel proteins and nucleic acids encoding same
AU2001234896A1 (en) Novel polypeptides and nucleic acids encoding same
EP1492807A4 (en) Novel proteins and nucleic acids encoding same
WO2002055558A8 (en) Novel proteins and nucleic acids encoding same
AU2002368398A1 (en) Novel proteins and nucleic acids encoding same
AU2002327198A1 (en) Novel proteins and nucleic acids encoding same
AU2002316064A1 (en) Novel proteins and nucleic acids encoding same
AU2002257014A1 (en) Proteins and nucleic acids encoding same
AU2001238408A1 (en) Novel proteins and nucleic acids encoding same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US US US US US US US US US US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

ENP Entry into the national phase in:

Ref document number: 2004115106

Country of ref document: RU

Kind code of ref document: A

122 Ep: pct application non-entry in european phase
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载